Clinical Trials in Washington

Showing 2581-2600 of 8,171 trials

Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder

NCT05600114

A phase 2, multicenter, double-blind, parallel group, placebo-controlled, randomized clinical study, designed to compare the efficacy, safety, and tolerability of 2 dose levels of CBD and a matching placebo for the treatment of subjects with Social Anxiety Disorder (SAD).

Social Anxiety Disorder

EmpowerPharm Inc.239 participantsStarted Oct 2022

Encino, California, United States • Lemon Grove, California, United States • Los Alamitos, California, United States +14 more locations

COMPLETEDPhase 336 miles

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

NCT03393520

This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786 compared to placebo, for the treatment of agitation in participants with dementia of the Alzheimer's type.

Agitation in Patients With Dementia of the Alzheimer's Type

Otsuka Pharmaceutical Development & Commercialization, Inc.601 participantsStarted Oct 2017

Chandler, Arizona, United States • Gilbert, Arizona, United States • Phoenix, Arizona, United States +208 more locations

Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Find Trials by Condition in Washington

A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)

Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy

Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.

Assessment of Heart Rate Measurement Accuracy for the PreemptiveAI SDK in Adults

A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)

A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

Multidisciplinary Approach for High-risk Patients Leading to Early Diagnosis of Canadians With Heart Failure

A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.